News

Harvard Bioscience, Inc.: Harvard Bioscience Announces CEO Succession Plan & Appointment of Two New Independent Directors to Board
Current Board member John Duke to succeed Jim Green as President & CEO Rob Gagnon and Seth Benson appointed as new Board membersQ2 '25 revenue anticipated to be $20.4 million and Company reiterates pr ...
The Manila Times10h
Harvard Bioscience Announces CEO Succession Plan & Appointment of Two New Independent Directors to Board
Current Board member John Duke to succeed Jim Green as President & CEO Rob Gagnon and Seth Benson appointed as new Board membersQ2 ’25 revenue anticipated to be $20.4 million and Company reiterates pr ...